Advisory Services Network, LLC Ocugen, Inc. Transaction History

Advisory Services Network, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 09, 2024	BUY	$0.36 - $0.57 $97 - $153	270 New	270 $0
Q1 2023 May 17, 2023	BUY	$0.82 - $1.33 $82 - $133	100 Added 37.04%	370 $0
Q4 2022 Feb 13, 2023	BUY	$1.11 - $1.87 $299 - $504	270 New	270 $0
Q3 2021 Nov 05, 2021	SELL	$6.36 - $8.51 $1,717 - $2,297	-270 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$5.52 - $15.68 $1,490 - $4,233	270 New	270 $2,000

128

79.5M

535K

523K

Ticker OCGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,566,000
Market Cap $158M
Description
Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company's pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmento...

Get notified when there are updates to the investment portfolio of Advisory Services Network, LLC, based on Form 13F filings with the SEC.

Stay updated on Advisory Services Network, LLC with notifications on news.